Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine Pentoxifylline and Ciprofloxacin with Dexamethasone.

dc.contributor.author	Turken, Orhan
dc.contributor.author	Orhan, Betül
dc.contributor.author	Öztürk, Ahmet
dc.contributor.author	Etiz, Durmuş
dc.contributor.author	Yaylacı, Mustafa
dc.contributor.author	Uskent, Necdet
dc.date.accessioned	2019-06-27T08:01:03Z
dc.date.available	2019-06-27T08:01:03Z
dc.date.issued	2001
dc.identifier.issn	0006-4971	en_US
dc.identifier.uri	https://hdl.handle.net/20.500.12469/232
dc.description.abstract	[Abstract Not Available]	en_US]
dc.language.iso	eng	en_US
dc.publisher	Amer Soc Hematology	en_US
dc.rights	info:eu-repo/semantics/closedAccess	en_US
dc.subject	N/A	en_US
dc.title	Patients with Myelodysplastic Syndromes benefit from therapy with Amifostine Pentoxifylline and Ciprofloxacin with Dexamethasone.	en_US
dc.type	conferenceObject	en_US
dc.identifier.startpage	276B	en_US
dc.identifier.endpage	276B
dc.relation.journal	Blood	en_US
dc.identifier.issue	11
dc.identifier.volume	98	en_US
dc.identifier.wos	WOS:000172134201254	en_US
dc.relation.publicationcategory	Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı	en_US

Files in this item

Files	Size	Format	View
There are no files associated with this item.